NENilufer Erkasap

Nilufer Erkasap

*This is an algorithmically generated author record based on publicly available information.

Nilufer Erkasap has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The synergistic effects of notch-1, IL-1β and leptin on migration and angiogenesis in colorectal cancer

    by Zeynep Erten Yücel, Fatıma Gülşen Özkan, Aysel Gültekin, Mete Ozkurt, Nılufer Erkasap

    Purpose: The aim of this study was to investigate the synergistic interaction of Notch-1, interleukin-1 beta, and leptin on each other, cell migration, and proangiogenic signaling in colorectal cancer cell lines.Materials and Methods: Human colorectal cancer cell lines, HCT-116 and HCT-15, were used. The genes for Notch-1, interleukin-1 beta, and leptin were silenced using small interfering ribonucleic acid. The efficacy of gene silencing and the messenger ribonucleic acid levels of target genes, including Notch-1, interleukin-1 beta, interleukin-1 receptor, leptin, vascular endothelial growth factor A, vascular endothelial growth factor receptor 2, and matrix metalloproteinase-2, were analyzed via quantitative real-time polymerase chain reaction. Protein levels of interleukin-1 beta, leptin, and vascular endothelial growth factor A were also measured using enzyme-linked immunosorbent assay.Results: In the Notch-1 inhibition group, significant decreases were observed in the messenger ribonucleic acid levels of Notch-1, interleukin-1 beta, interleukin-1 receptor (a 3.45-fold decrease), leptin, vascular endothelial growth factor receptor 2, and matrix metalloproteinase-2 (a 6.36-fold decrease). Leptin inhibition led to reduced messenger ribonucleic acid levels of Notch-1, interleukin-1 beta (a 3.67-fold decrease), interleukin-1 receptor (a 2.53-fold decrease), leptin, vascular endothelial growth factor A, and matrix metalloproteinase-2 (a 3.22-fold decrease). Conclusion: Notch-1, interleukin-1 beta, and leptin interact with each other, directly contributing to cell migration and the expression of angiogenic molecules in colorectal cancer.

  • Open Access

    Abstract 1491: Effect of NILCO Inhibition on MMP2 and VEGFA in Colon Cancer Cells

    by Nilufer Erkasap, Aysel Ayata, Mete Ozkurt, Rumeysa Ozyurt

  • Open Access

    The effects of quercetin on erythropoietin, hypoxia-inducible factors-1α, 2α, and pyroptosis related genes expression levels in inflammation induced by TNF-α and LPS in HepG2 cells

    by Mete Ozkurt, Burcu Akinci, Selda Kabadere Deli̇oRman, Rumeysa Özyurt, Abdullah Karadağ, Nilüfer Erkasap

    Purpose: TNF-α, which increases in the circulation as a result of systemic inflammation, suppresses the production of the erythropoiesis regulating hormone, erythropoietin (EPO) and causes inflammation anemia. The anti-inflammatory activity of quercetin has been reported in different studies. However, no study has been found showing the effect of this situation on EPO gene expression. For this purpose, we evaluated the effects of quercetin on inflammation and, more importantly, its effects on EPO, suppressed in the inflammatory environment and Hypoxia-inducible factors (HIF), which are stimulators of EPO synthesis. In addition, we aimed to evaluate the effect of quercetin on pyroptosis, which is defined as pro-inflammatory programmed cell death. Materials and Methods: We created inflammation models with TNF-α or LPS using HepG2 cells in vitro. In these inflammation models, we evaluated the effects of quercetin on proinflammatory mediators TNF-α, IL-1α, NF-κB gene expressions, EPO, HIF-1α, HIF-2α gene expressions, as well as pyroptosis-related caspase 1 and IL-18 gene expressions. Results: Quercetin showed inflammatory effects by increasing TNF-α, IL-1α, and NF-κB mRNA levels. Consistent with this inflammatory effect, EPO mRNA expression was suppressed. HIF-1α and HIF-2α mRNA levels were increased. Conclusion: These results suggested that the increase in HIFs could not prevent the suppressive effect of inflammatory cytokines and NF-κB on EPO production. However, it has been observed that it tends to suppress proinflammatory cell death by decreasing caspase 1 and IL-18 mRNA levels. These results show that quercetin may show conflicting effects, and further studies are needed to test its safety.

  • Open Access

    The Effect of Antioxidant Astaxanthin on Intestinal Ischemia Reperfusion Damage in Rats

    by Arda Sakir Yilmaz, Bartu Badak, Nilufer Erkasap, Mete Ozkurt, Ertugrul Colak

    Mesenteric ischemia is a frequently encountered disease in surgical clinics, difficult to diagnose, and very mortal if not treated. Our study investigated the effects of astaxanthin, which is known...


  • Open Access

    Investigation of the Anti-inflammatory Effects of Astaxanthin on Liver Tissue in Lipopolysaccharide-induced Sepsis in Rats

    by Nurdan Çobaner, Birgül Yelken, Nilufer Erkasap, Mete Özkurt, Ezgi Bektur

    Amaç: Kortikosteroidler enflamasyonu önlemek için sepsiste kullanılan tedavi yöntemlerinden biridir. Çalışmamızda astaksantinin sepsiste anti-enflamatuvar aktivitesini göstermeyi ve deksametazon ile karşılaştırmayı amaçladık. Gereç ve Yöntem: Yerel etik komitenin onayından sonra, 40 Sprague-Dawley erkek sıçan randomize olarak kontrol grubu (n=8), lipopolisakkarit grubu (n=8), astaksantin grubu (n=8), astaksantin + lipopolisakkarit grubu (n=8) ve deksametazon + lipopolisakkarit grubu (n=8) olarak belirlendi. İlk gün bu gruplara sırasıyla dimetil sülfoksit, Salmonella typhimurium lipopolisakkariti, dimetil sülfoksit içinde çözünmüş astaksantin, astaksantin ve lipopolisakkarit ve deksametazon verildi. Yirmi dördüncü saatin sonunda sıçanlara laparotomi yapılarak karaciğer ve kan örnekleri alındı. İstatistiksel analiz için GraphPad Prism6 programı kullanıldı. 0,05’ten küçük p değerleri anlamlı kabul edildi. Bulgular: Lipopolisakkarit grubu ile karşılaştırıldığında, her iki tedavi grubunda da nükleer faktör-kappa B seviyelerinde istatistiksel olarak anlamlı bir düşüş vardı. Tedavi gruplarında lipopolisakkarit grubuna göre apoptotik hücreler ve reaksiyon şiddeti anlamlı olarak azaldı. Sonuç: Astaksantin kullanımının, karaciğer dokusunda sepsis tedavisi konusunda olumlu bir etkisi olduğunu bulduk. Farklılıklar olmasına rağmen, deksametazon uygulamasına kıyasla benzer ölçüm değerleri elde edildi.

  • Open Access

    The role of anakinra in the modulation of intestinal cell apoptosis and inflammatory response during ischemia/reperfusion

    by Muhammed Kandemi̇r, Necdet Fatih Yaşar, Mete Özkurt, Rumeysa Özyurt, Nuriye Ezgi Bektur Aykanat, Nilüfer Erkasap

    Even though interleukin-1 receptor antagonist, IL-1Ra, is used in certain inflammatory diseases, its effect on ischemia-reperfusion injury is a current research topic. We aimed to investigate the protective effects of anakinra, an IL-1Ra, on the I/R induced intestinal injury. The rat model of intestinal ischemia-reperfusion was induced. Rats were randomized into four groups: (group 1) control group, (group 2) I/R group, (group 3 and 4) treatment groups (50mg/kg and 100mg/kg, respectively). Gene expressions of Caspase-3, TNF-?, IL-1?, IL-6, and apoptotic cells in tissue samples were evaluated by PCR and TUNEL methods, respectively. Plasma levels of SOD, CAT, and MDA were studied by the ELISA method and tissue samples were examined histopathologically as well. Anakinra inhibited the expression of IL-1?, IL-6, and TNF-? and decreased the SOD, CAT, and MDA caused by ischemia-reperfusion injury in both treatment groups. Caspase-3 expression and TUNEL-positive cell number in treatment groups as well were less. Histopathologically, anakinra better preserved the villous structure of the small intestine at a dose of 100 mg/kg than 50 mg/kg. Anakinra decreased the intestinal damage caused by ischemia-reperfusion and a dose of 100mg/kg was found to be histopathologically more effective.


  • Open Access

    miR663 Prevents Epo Inhibition Caused by TNF-Alpha in Normoxia and Hypoxia

    by Mete Ozkurt, Thomas Hellwig-Bürgel, Reinhard Depping, Selda Kadabere, Rumeysa Ozyurt, Abdullah Karadag, Nilüfer Erkasap

    Objective. In chronic inflammatory diseases, proinflammatory cytokines such as TNF-α are present in high amounts in the circulation and are associated with anemia in most cases. Experimental studies have shown that TNF-α inhibits the synthesis of erythropoietin (Epo), the main stimulant of hematopoiesis. Our aim was to figure out which microRNAs are involved in the Epo repression by TNF-α. Methods. First, we determined the dose of TNF-α in HepG2 cells that has no cytotoxic effect by using MTT assays and that inhibits Epo synthesis by qRT-PCR and ELISA. Then, we performed the microRNA array study with TNF-α (20ng/ml)-treated cells, and the array results were confirmed by qRT-PCR. We transfected the miR663 group with the mimic-miR663 (30 pmol) for 24hrs; other groups were treated with a transfection reagent followed by treatment of TNF-α for 24hrs; miR663 groups were treated with TNF-α for 24hrs; and the control group was incubated with normal medium. We analyzed Epo mRNA levels by qRT-PCR. If mimic-miR663 prevents the Epo repression by TNF-α, more Epo-dependent UT-7 cells would survive. Therefore, we cocultured HepG2 cells with UT-7 cells. The percentage of apoptotic UT-7 cells was determined by TUNEL assays. Results. According to our array study, TNF-α significantly decreases miR663 expression. After transfection of miR663 mimics into HepG2 cells, TNF-alpha was unable to decrease Epo mRNA amounts. Furthermore, mimic-miR663 transfection resulted in a lower apoptosis rate of UT-7 cells in coculture experiments. Conclusions. miR663 is involved in Epo mRNA production and that is able to prevent or reverse the inhibitory effect of TNF-α. In our coculture study, transfecting HepG2 cells with miR663 mimics decreased the apoptosis of UT-7 cells.


  • Open Access

    Ceranib-2, HIF1-α gen ekspresyonunu inhibe eder ve HepG2 hücrelerinde apoptozu indükler

    by Rumeysa Özyurt, Mete Ozkurt, Abdullah Karadağ, Cemile Meral, Nılufer Erkasap

    Purpose: The aim of this study is to investigate the apoptotic effect of a novel anti-cancer drug, ceranib-2 and impact on HIF-1α levels on HepG2. Materials and Methods: The cell line was treated in vitro with 0,1, 1, 5, 10, 25 and 50 µM ceranib-2 for 24 and 48 hours and cell viabilitiy was determined. mRNA levels of acid ceramidase, caspase-3, caspase-8, caspase-9, Cyc1, HIF-1α and TNF-α were measured by qPCR. Results: Ceranib-2 at 10 µM concentration reduced the viability by about 58 % after 24 and 48 hours. The same dose increased mRNA level of caspase-3 and no change was detected on caspase-8 when compared to the control group after 24 hours. No difference was detected on caspase-3, but caspase-8 mRNA level increased after 48 hours with ceranib-2 at 10 µM concentration. Caspase-9 mRNA levels did not differ after 24 and 48 hours. Ceranib-2 at 10 µM concentration lowered mRNA level of Cyc1 against the control group after the 24- hour treatment. ASAH mRNA level was reduced after the 48-hour treatment with 10 µM ceranib-2. Reduction of ASAH indicated that 10 µM ceranib-2 could inhibit ceramidase after 48 hours and this may elavate ceramide concentration. TNF-α mRNA increased after 24 and 48 hours, but HIF-1α expression was low after 24 hours when compared to the control group. Conclusion: We have found that ceranib-2 induces apoptosis in HepG2, thus ceranib-2 may play an anti-cancer role at 10 µM concentration.